High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusion
Verena Nilius‐Eliliwi(Universitätsklinikum Knappschaftskrankenhaus Bochum), Cornelia Brendel(Philipps University of Marburg), Elisabeth Mack(Universitätsklinikum Gießen und Marburg), Anja Lorch(Massachusetts Eye and Ear Infirmary), Andreas Neubauer(RWTH Aachen University), Michael Lohoff(Philipps University of Marburg), Andreas Burchert(Philipps University of Marburg), Roland Moll(Philipps University of Marburg), Nina Timmesfeld(Zimmer Biomet (Germany)), Melina Schmitt(Philipps University of Marburg), Madeleine C. Killer
Cited by 11
Related Papers
The human keratins: biology and pathology
|Histochemistry and Cell Biology|2008|1.4k
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573